Pluripotent stem cell-based cancer therapy: Promise and challenges

Saul J. Sharkis, Richard J. Jones, Curt Civin, Yoon Young Jang

Research output: Contribution to journalReview articlepeer-review

Abstract

The development of induced pluripotent stem cell (iPSC) technology has generated enthusiasm about the therapeutic potential of these cells for treating a variety of diseases. However, the evidence that they actually will be clinically useful is limited. Here, we discuss the potential therapeutic applications of iPSCs for treating cancer and other diseases and highlight the current barriers restricting their use.

Original languageEnglish (US)
Article number127ps9
JournalScience translational medicine
Volume4
Issue number127
DOIs
StatePublished - Mar 28 2012

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Pluripotent stem cell-based cancer therapy: Promise and challenges'. Together they form a unique fingerprint.

Cite this